Long-term proliferation and dopaminergic differentiation of human mesencephalic neural precursor cells

被引:229
作者
Storch, A [1 ]
Paul, G
Csete, M
Boehm, BO
Carvey, PM
Kupsch, A
Schwarz, J
机构
[1] Univ Ulm, Sch Med, Dept Neurol, Ulm, Germany
[2] Univ Ulm, Sch Med, Dept Internal Med, Ulm, Germany
[3] Humboldt Univ, Charite, Dept Neurol, Berlin, Germany
[4] Univ Michigan, Dept Anesthesiol, Ann Arbor, MI 48109 USA
[5] CALTECH, Div Biol, Pasadena, CA 92215 USA
[6] Rush Presbyterian St Lukes Med Ctr, Dept Pharmacol, Chicago, IL 60612 USA
[7] Rush Presbyterian St Lukes Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA
关键词
precursor cells; human; dopamine neurons; mesencephalon; cytokines; glial cell line-derived neurotrophic factor; differentiation; Parkinson's disease;
D O I
10.1006/exnr.2001.7706
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
We report on generation of dopamine neurons from long-term cultures of human fetal mesencephalic precursor cells. These CNS precursor cells were successfully expanded in vitro using the mitogens epidermal growth factor (EGF) and fibroblast growth factor-2 (FGF-2). Incubation of these cultures in 3% atmospheric oxygen resulted in higher cellular yields than room air. Following incubation in differentiation media containing interleukin (IL)-1b (IL-1b), IL-11, leukemia inhibitory factor (LIF), and glial cell line-derived neurotrophic factor (GDNF), up to 1% of the precursor cells converted into cells immunoreactive for tyrosine hydroxylase (TH), a marker for dopamine neurons. The TH immunoreactive cells exhibited morphological and functional properties characteristic of dopamine neurons in culture. These precursor cells might serve as a useful source of human dopamine neurons for studying the development and degeneration of human dopamine neurons and may further serve as a continuous, on-demand source of cells for therapeutic transplantation in patients with Parkinson's disease. (C) 2001 Academic Press.
引用
收藏
页码:317 / 325
页数:9
相关论文
共 38 条
  • [1] ETHICAL GUIDELINES FOR THE USE OF HUMAN EMBRYONIC OR FETAL TISSUE FOR EXPERIMENTAL AND CLINICAL NEUROTRANSPLANTATION AND RESEARCH
    BOER, GJ
    [J]. JOURNAL OF NEUROLOGY, 1994, 242 (01) : 1 - 13
  • [2] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [3] CARVEY PM, 2000, ABS SOC NEUR, V26, P2056
  • [4] Daadi MM, 1999, J NEUROSCI, V19, P4484
  • [5] Prospects for new restorative and neuroprotective treatments in Parkinson's disease
    Dunnett, SB
    Björklund, A
    [J]. NATURE, 1999, 399 (6738) : A32 - A39
  • [6] DOPAMINE SYNTHESIS PRECEDES DOPAMINE UPTAKE IN EMBRYONIC RAT MESENCEPHALIC NEURONS
    FISZMAN, ML
    ZUDDAS, A
    MASANA, MI
    BARKER, JL
    DIPORZIO, U
    [J]. JOURNAL OF NEUROCHEMISTRY, 1991, 56 (02) : 392 - 399
  • [7] Mammalian neural stem cells
    Gage, FH
    [J]. SCIENCE, 2000, 287 (5457) : 1433 - 1438
  • [8] Sequential bilateral transplantation in Parkinson's disease -: Effects of the second graft
    Hagell, P
    Schrag, A
    Piccini, P
    Jahanshahi, M
    Brown, R
    Rehncrona, S
    Widner, H
    Brundin, P
    Rothwell, JC
    Odin, P
    Wenning, GK
    Morrish, P
    Gustavii, B
    Björklund, A
    Brooks, DJ
    Marsden, CD
    Quinn, NP
    Lindvall, O
    [J]. BRAIN, 1999, 122 : 1121 - 1132
  • [9] ETHICAL ISSUES IN BRAIN-CELL TRANSPLANTATION
    HOFFER, BJ
    OLSON, L
    [J]. TRENDS IN NEUROSCIENCES, 1991, 14 (08) : 384 - 388
  • [10] CONTROL OF NEURONAL DIVERSITY BY THE FLOOR PLATE - CONTACT-MEDIATED INDUCTION OF MIDBRAIN DOPAMINERGIC-NEURONS
    HYNES, M
    POULSEN, K
    TESSIERLAVIGNE, M
    ROSENTHAL, A
    [J]. CELL, 1995, 80 (01) : 95 - 101